Researchers on Wednesday reported two promising new approaches to counteract malaria’s growing resistance to medication — one involving a new class of drugs. Switzerland-based Novartis released results of what it called a next-generation treatment. A study of its experimental drug in 12 African countries found it works well against the mosquito-borne parasite that causes malaria and seems to block spread.

Entering a prospective employee meeting can be overwhelming, particularly when the discussion goes to compensation. For medical attendants, whether recently qualified or

"Virgil has two personalities, its 'good' side – a typical young galaxy quietly forming stars. But Virgil transforms into the host of a heavily obscured supermassive black hole, pouring out immense quantities of energy."